NCT02624804View on ClinicalTrials.gov

A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

November 11, 2022

Study Completion Date

March 11, 2024

Conditions
Diabetes Mellitus Type 1
Interventions
BIOLOGICAL

Stem Cell Educator Therapy

"Patients will receive apheresis and then have their own blood returned to them with the educated lymphocytes"

Trial Locations (1)

07601

Hackensack University Medical Center - John Theurer Cancer Center, Hackensack

All Listed Sponsors
lead

Hackensack Meridian Health

OTHER

NCT02624804 - A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes | Biotech Hunter | Biotech Hunter